Key result
The purine-rich region of the Rous sarcoma virus negative regulator of splicing acts as an RNA splicing enhancer required for efficient splicing inhibition.
The purine-rich region of the Rous sarcoma virus NRS provides an RNA splicing enhancer function required for splicing inhibition, likely facilitating snRNP binding via SF2/ASF.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for retroviral splicing; requires validation in human models before any translational consideration.
McNally et al. (1998) studied Rous sarcoma virus infection. NRS purine-rich region vs. Mutant/deleted NRS regions was evaluated on Splicing inhibition. The purine-rich region of the Rous sarcoma virus negative regulator of splicing acts as an RNA splicing enhancer required for efficient splicing inhibition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: